New Era targets Phase 1 timing in 4Q 2027 while advancing 757 MW behind-the

·18 Aug
Share:PostShare

NUAI Q2 2026 earnings call recap: permits secured, PPA talks nearing approval, cash & facility update, and 4Q’27 Phase 1 target.

S

Seeking Alpha

Original source

Read full story

new era

Check live status on DownRightNow

Check status →

Related Stories

Business51m ago

Sun Pharma agrees to lower US drug prices under Trump plan; analysts see limited financial impact

Sun Pharmaceutical Industries will offer its drugs at prices matching other developed nations. This agreement aims to make healthcare affordable for low-income Americans. Analysts believe the financial impact on Sun Pharma will be minimal. The company's US revenue contribution is significant, reinforcing its growth strategy. This pact recognizes Sun Pharma's investment in the American market.

TThe Economic Times

Headlines and briefs on this site are for information only. Always verify details on the original source or live status page.

Read Disclaimer